[Deep sclerectomy for the management of XXXX ].

@entity1 @entity32 @entity231 @entity1596 @entity726 @entity260 @entity5891
PURPOSE: To report middle-term results of deep sclerectomy in @entity1596 @entity1 with @entity726 who are resistant to medical therapy. @entity1 AND METHODS: Eight eyes of eight @entity1 (mean age, 56.9 years; range, 46-67 years) with @entity726 resistant to medical therapy underwent deep sclerectomy without antimetabolites between 1994 and 2001. All @entity1 had their @entity1596 controlled before and after surgery by anti-inflammatory therapy. RESULTS: Mean follow-up was 42.2 months. Intraocular pressure was reduced from a mean preoperative value of 32.3 mmHg to a mean postoperative value of 15.2 (52.9% reduction). Success was obtained in seven eyes (87.5%). It was complete in four eyes (57.2%) and relative in three eyes (42.8%). Failure was noted in one eye (12.5%), controlled later by trabeculectomy. Antiglaucomatous medication was reduced from a mean of 2.9 medications preoperatively to 0.6 medications (79.3% reduction). @entity260 included one case of @entity231 and one case of @entity5891 . CONCLUSION: The low rate of surgical complications and the lack of failure risk factors except @entity32 and long-term use of antiglaucomatous medication may explain the high success rate of deep sclerectomy in this study.
